CorMedix CRMD Debt-to-equity

Debt-to-equity at other companies

PfizerPFE

0.7×0.0×

Merck & Co.MRK

1.4×+0.6×

Merit Medical SystemsMMSI

0.5×-0.1×

IAR

Integra LifeSciencesIART

1.9×+0.1×

ICU MedicalICUI

0.6×-0.1×

TFX

TeleflexTFX

1×+0.6×

FAQ

What is CorMedix's debt-to-equity?

CorMedix (CRMD) reported debt-to-equity of 0× in Q4 2025.

How has CorMedix's debt-to-equity changed year-over-year?

CorMedix's debt-to-equity increased by 73.8% year-over-year, from 0× to 0×.

What is the long-term trend for CorMedix's debt-to-equity?

Over 5 years (2020 to 2025), CorMedix's debt-to-equity has grown at a -14.6% compound annual growth rate (CAGR), from 0× to 0×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.